IMMUNOVIA AB
1YRStockF
€0.00 ▲ +0.00%
12 juin 2026
1
IMMUNOVIA AB
€0.00 ▲ +0.00%
12 juin 2026
1YRStockF

01 / À propos

Immunovia AB (publ), a diagnostic company, develops and validates blood test for detecting pancreatic cancer in Sweden. It also focuses on the development and commercialization of blood-based testing to detect proteins and antibodies that indicate pancreatic cancer in an individual. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.

Arberion
Loading market data